Agenus is a Lexington, Massachusetts biotechnology company developing immunotherapies for cancer and autoimmune diseases. It last closed at $5.97 on Nov 20, down 2.77% on the day. The next earnings report for AGEN is expected around Mon, Mar 15, 2027. For the quarter ended Sep 2026, AGEN reported EPS of $0.02 on revenue of $31.5M, with revenue up 4.1% from a year ago. Over its last 8 reports the stock moved an average of 9.2% the session after earnings.
AI Auto Pilots
Is AGEN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AGEN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AGENStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AGEN · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 12% below its 20 day and 22% below its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 39). The nearest support is the Pivot S1 at $5.83, and the nearest resistance the Pivot at $6.04.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 8.5%/day
Key levels
$10.3152 week high+72.7%
$7.30Swing high (Oct 29)+22.3%
$7.2650 day average+21.6%
$6.92100 day average+15.9%
$6.6820 day average+11.9%
$6.19Pivot R1+3.7%
$6.04Pivot+1.2%
$5.97Last close
$5.83Pivot S1−2.3%
$5.19200 day average−13.1%
$3.10Swing low (Jul 10)−48.1%
$2.7152 week low−54.6%
Indicators
RSI (14)
38.76
Weak, oversold below 30
Neutral
MACD
-0.24
Below its signal line
Bearish
Stochastic
19.5
Near the bottom of its range
Oversold
ADX (14)
20.1
Weak trend
Williams %R
-88.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-133.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−16.5%
Change over 10 sessions
Bearish
ATR (14)
$0.51
Typical daily range, 8.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumFading
StretchNormal
VolatilityNormal, 20.0%/day
Key levels
$10.3152 week high+72.7%
$7.30Swing high (Oct 29)+22.3%
$7.2650 day average+21.6%
$6.92100 day average+15.9%
$6.6820 day average+11.9%
$6.19Pivot R1+3.7%
$6.04Pivot+1.2%
$5.97Last close
$5.83Pivot S1−2.3%
$5.19200 day average−13.1%
$3.10Swing low (Jul 10)−48.1%
$2.7152 week low−54.6%
Indicators
RSI (14)
48.55
Middle of its range
Neutral
MACD
0.54
Below its signal line
Bearish
Stochastic
16.2
Near the bottom of its range
Oversold
ADX (14)
42.5
Strong uptrend
Williams %R
-95.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-70.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−14.0%
Change over 10 sessions
Bearish
ATR (14)
$1.20
Typical daily range, 20.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Below
What happened before, for AGEN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AGEN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow AGEN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AGENHow many large options trades hit AGEN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AGEN in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AGEN is in one of them and how their past AGEN trades turned out.
Agenus is a biotechnology company based in Lexington, Massachusetts. It is developing immunotherapy product candidates aimed at cancer and autoimmune diseases. Its target customers are physicians and patients, and sales depend heavily on coverage and reimbursement from insurers and government healthcare programs. Its product candidates have not yet received marketing approval, and it competes with established treatments such as chemotherapy and radiation therapy.